Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes

Folia Histochemica et Cytobiologica

Volumn 47, Issue 4, 2009, Pages 593-598

  Antosz, Halina ^a   Sajewicz, Joanna ^a   Marzec Kotarska, Barbara ^a   Kocki, Janusz ^a   Dmoszyñska, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

B CLL; CD14; CD180; CD284

Indexed keywords

CD14 ANTIGEN; CD180 ANTIGEN; CD19 ANTIGEN; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE SUBPOPULATION; PERIPHERAL LYMPHOCYTE; VOLUNTEER;

EID: 77954393921     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0112-1     Document Type: Article

References (23)

1. Hus I, Bojarska-Junak A, Dmoszyñska A et al. ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukemia and com- bined analysis improves their predictive value. Folia His- tochem Cytobiol. 2008;46:147-152.
2. Bojarska-Junak A, Roliñski J, Kawiak J. Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia. Folia Histochem Cytobiol. 2005;43:19-23.
3. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.
4. Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, Jego G. Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood. 2008;112:2205-2213.
5. Kawai T, Akira S. TLR signaling. Semin Immunol. 2007;19: 24-32.
6. Akira S. Mammalian Toll-like receptors. Current Opinion Immunol. 2003;15:5-11.
7. Miura Y, Shimazu R, Miyake K et al. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood. 1998;92:2815-22.
8. Ogata H, Su I, Miyake K et al. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med. 2000;192:23-29.
9. Akashi S, Shimazu R, Ogata H et al. Cell surface expression and LPS signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol. 2000;164: 3471-3475.
10. Miyake K, Shimazu R, Kondo J et al. MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J Immunol. 1998;161:1348-1353.
11. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990:1431-1433.
12. Sugiyama T. The expression of embrane-bound CD14 renders mouse B-1 susceptible to LPS. J Endotoxin Res. 2001;7: 223-226.
13. Triantafilou K, Triantafilou M, Dedrick RL. A CD14-inde- pendent LPS receptor cluster. Nat Immunol. 2001;2:338-345.
14. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219-234.
15. Chiorazzi N, Rai KR, Ferrarini M. Mechanizm of disease chronic lymphocytic leukemia. N Engl J Med. 2005;352:804-815.
16. Muzio M, Scielzo C, Bertilaccio MT, Frenquelli M, Ghia P, Caligaris-Cappio F. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Br J Hae- matol. 2009;144:507-16.
17. Divanovic S, Trompette A, Atabani SF et al. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J Endotoxin Res. 2005;11:363-8.
18. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition. CD14,TLRs and LPS-activation cluster. Trends in Immunol. 2002;23:301-304.
19. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 2002;168:554-561.
20. Divanovic A, Trompette SF, Atabani R et al. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. Innate Immunit. 2005;11:363-368.
21. Divanovic S, Trompette A, Petiniot LK et al. Regulation of TLR4 signalling ad the host interface with pathogens and dan- ger: the role of RP105. J Leukocyte Biol. 2007;82:265-271.
22. Plate J. Signals that maintain leukemic cell viability. Blood. 2008;112:1-2.
23. Muzio M, Apollonio B, Scielzo C et al. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood. 2008;112: 188-195.